Severe Proliferative Diabetic Retinopathy
NCT01115257 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2010-05-04
Summary
The purpose of this study is to examine and compare, prospectively, best corrected visual acuity (BCVA) outcomes and complications of a cohort of patients with Proliferative Diabetic Retinopathy and Tractional Retinal Detachment not involving macula undergoing pars plana vitrectomy (PPV) or conventional management (panretinal photocoagulation).
Conditions
Interventions
- PROCEDURE
-
vitrectomy
The surgical technique (Group 1) included vitrectomy, with a combination of delamination and segmentation of gliotic tractional membranes using bimanual technique. Silicone oil tamponade was used in eyes with long-standing tractional retinal detachment, as deemed necessary by the surgeon, or in eyes in which a retinal break occurred during the vitrectomy.
- PROCEDURE
-
panretinalphotocoagulation
Panretinal photocoagulation was completed according to guidelines summarized in ETDRS with extensive full subconfluent panretinal photocoagulation.
Sponsors & Collaborators
-
Universita degli Studi di Catania
lead OTHER
Principal Investigators
-
Teresio Avitabile, Professor · universita studi di Catania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-31
- Primary Completion
- 2006-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Phenotyping Diabetic Retinopathy
NCT00840541 ·Status: COMPLETED
-
Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy
NCT02911311 ·Status: UNKNOWN ·Phase: NA
-
Effect of Argon Laser Panretinal Photocoagulation on Corneal Endothelial Cell Density .
NCT07157553 ·Status: NOT_YET_RECRUITING
-
Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients
NCT05631054 ·Status: UNKNOWN
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
NCT01921192 ·Status: UNKNOWN ·Phase: PHASE4
-
Macular Vessels Density Before and After PRP in Patients With Proliferative Diabetic Retinopathy
NCT04976361 ·Status: COMPLETED ·Phase: NA
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy
NCT02309502 ·Status: WITHDRAWN ·Phase: NA
-
Pharmacological Intervention in Diabetic Retinopathy
NCT00619034 ·Status: COMPLETED ·Phase: NA
-
Propranolol for Diabetic Retinopathy
NCT01535495 ·Status: COMPLETED ·Phase: PHASE1
-
Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
NCT02816710 ·Status: COMPLETED ·Phase: PHASE4
-
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652 ·Status: RECRUITING
-
Effect of Laser Treatment for Diabetic Retinopathy on the Optic Disc Topography
NCT03476967 ·Status: COMPLETED
-
Study of Natural Course Progression of Diabetic Retinopathy
NCT06269419 ·Status: RECRUITING
-
Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy
NCT03633266 ·Status: UNKNOWN ·Phase: NA
-
25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
NCT02328118 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Aflibercept Injection for Proliferative Diabetic Retinopathy
NCT01805297 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Retinopathy Study (DRS)
NCT00000160 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Follow-Up of Diabetic Retinopathy
NCT00001395 ·Status: COMPLETED
-
Diabetes PRP and OCT
NCT01928550 ·Status: COMPLETED
-
Macular Tractional Retinoschisis in Proliferative Diabetic Retinopathy
NCT01312207 ·Status: UNKNOWN
-
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
NCT06549023 ·Status: RECRUITING ·Phase: NA
-
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
NCT02837640 ·Status: UNKNOWN ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR
NCT07230184 ·Status: COMPLETED ·Phase: PHASE4